Case of Giant Cell Arteritis After SARS-CoV-2 Vaccination: A Particular Phenotype?

Sauret, Agathe; Stievenart, Julien; Smets, Perrine; Olagne, Louis; Guelon, Benedicte; Aumaître, Olivier; André, Marc; Trefond, Ludovic

Sauret, Agathe; Stievenart, Julien; Smets, Perrine; Olagne, Louis; Guelon, Benedicte; Aumaître, Olivier; André, Marc; Trefond, Ludovic.

Sauret A; CHU Clermont-Ferrand, Service de Médecine Interne, Hôpital Gabriel Montpied.
Stievenart J; CHU Clermont-Ferrand, Service de Médecine Interne, Hôpital Gabriel Montpied.
Smets P; CHU Clermont-Ferrand, Service de Médecine Interne, Hôpital Gabriel Montpied.
Olagne L; CHU Clermont-Ferrand, Service de Médecine Interne, Hôpital Gabriel Montpied.
Guelon B; CHU Clermont-Ferrand, Service de Médecine Interne, Hôpital Gabriel Montpied.
Aumaître O; CHU Clermont-Ferrand, Service de Médecine Interne, Hôpital Gabriel Montpied.
André M; Université Clermont Auvergne, Inserm U1071, INRA USC2018, M2iSH, Clermont-Ferrand, France.
Trefond L; CHU Clermont-Ferrand, Service de Médecine Interne, Hôpital Gabriel Montpied.

J Rheumatol ; 49(1): 120, 2022 01.

Article in English | MEDLINE | ID: covidwho-1448971

Subject(s)

COVID-19; Giant Cell Arteritis; COVID-19 Vaccines; Humans; Phenotype; SARS-CoV-2; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Giant Cell Arteritis / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Rheumatol Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google